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1. Introduction 
The incidence of sport injuries has increased in recent years due to fitness training and 
growing participation in sport activities by the general public. The tendon rupture was 
regarded as an injury typical of high-performance athletes. As physical and recreational 
activities become more and more popular followed by an increased frequency of soft 
tissue injuries, health care costs are raising. Tendon lacerations, ruptures, or inflammation 
cause marked morbidity and has a major impact on work, recreational activities, and daily 
needs. Tendon ruptures and tears are slow healing injuries that are often treated 
surgically with unsatisfactory results for some patients. As biology of healing processes 
and the influence of growth factors are becoming more and more clear, one can consider 
introducing biological therapy into clinical use. For optimizing treatment more 
understanding is needed. Therefore tendon physiology, pathology, ruptures biology and 
functionality, normal healing process, as well as the role of polypeptide factors during 
healing need to be known. 
The injury itself initiates several pathways of signalling that recruits fibroblasts and 
stimulates tenocytes for collagen synthesis and other extracellular components. Together 
with some mechanical stress, the healing process is able to restore tendon tissue partially or 
sometimes close-to-normal. However, repaired tendon tissue rarely achieves functional 
normal tendon. To improve such results, this complex process requires a combination of 
treatments as: non-operative or operative treatment to restore length, early functional 
therapy for mechanical stimulation, and tissue engineering to provide additional growth 
factors.  
These treatment modalities may improve tissue healing, tendon gliding, mechanical 
strength, and return to normal function while preventing tendon gapping, ruptures, and 
extensive adhesions. Recent advances in bioengineering including the use of growth factors, 
mesenchymal stem cells and biocompatible scaffolds are promising. 
Although the effect of growth factors on tendon healing is impressive, it has become 
increasingly clear that tendon repair is not triggered by a single growth factor but requires 
the interplay of various such factors. Collectively, they exert powerful and comprehensive 
effects on healing. Therefore further research is needed. 
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2. Tendon structure and healing 
2.1 Tendon structure 
Tendons functionally connect the dynamic and static components of the locomotive 
apparatus. Disturbances in the propagation of force from muscle to bone are associated with 
a considerable loss of function of the extremity. In order to fulfill these functions tendons 
have special morphological characteristics: fibers are closely packed in a parallel 
arrangement. The high collagen content and the parallel orientation of the fibers give them 
extraordinary tensile strength, the highest of any tissue in the body. This characteristic 
results, for the most part, from the composition and structure of the collagen and elastic 
fibers, and their interplay. Collagen accounts for 70% of the dry weight of tendons, 95% of 
which is collagen type I and to a smaller extent elastin (Birk & Trelstad, 1984; Molloy et al., 
2003). The remaining 5% is composed of collagen type III as well as a glycosaminoglycan 
component of approximately 0.5% (Ducy & Karsenty, 2003; Gerich et al., 1996). Collagen is 
rich in proline and glycine and contains hydroxyproline and hydroxylysine. Lysine and 
proline residues get hydroxylated within fibroblasts. Hydroxyproline and hydroxylysine are 
important in maintaining tendon structure; they form H-bridges and hydroxylysine residues 
are involved in the covalent cross-linking of collagen fibers (Molloy et al., 2003). The 
individual collagen fibers are arranged in fascicles that contain nerve fibers, blood and 
lymph vessels (Petersen et al., 2003a; Petersen et al., 2004). Within the fascicles there exist 
specialized fibroblasts called tenocytes, which exhibit a high degree of organization. 
Vertically they appear star-like and longitudinally they appear to be arranged in a row 
along the fibers. This special orientation of the cells reflects their function. These cells are 
capable of synthesizing fibrillose as well as non-fibrillar components of the extracellular 
matrix and can also resorb collagen fibers (Chan et al., 1997; Gerich et al., 1996). The fascicles 
are covered with epitenon, which in turn is covered with paratenon. A fluid film lies 
between these two layers, which make the movements of the tendon possible. 
2.2 Tendon healing 
Study of the physiology of tendon healing has revealed two mechanisms of healing, intrinsic 
and extrinsic healing (Grotendorst, 1988; Hefti & Stoll 1995). During intrinsic healing the 
tendon with the surrounding tendon sheath are obliterated. The healing of defects between 
the tendon ends consists of an exudative and a formative phase which are for the most part 
similar to wound healing in other parts of the body (Maffulli et al., 2000). The concept of 
extrinsic tendon healing is based on the fact that the cells responsible for the process migrate 
from the peripheral tendon sheath to the area of the defect (Özkan et al., 1999). This was 
seen in animal experiments, where fibroblasts and newly formed collagen fibers in the first 
days after the injury were arranged in a radial manner and then after several days oriented 
in a longitudinal fashion according to the stress load profile of the tendon. It is now 
assumed that both extrinsic and intrinsic tendon healing play important roles. Tendon 
healing can be summarized as follows (Gerich et al., 1996). 
2.3 The three phases of tendon healing 
Tendon healing occurs in three phases, an inflammatory, a repair, and a remodeling phase 
(Lou et al., 1996). The inflammatory phase occurs during the first three to five days after 
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injury. It is characterized by the migration and proliferation of cells from the extrinsic 
peritendonal tissue such as the paratenon, subcutaneous fat tissue and fascia and the 
intrinsic epitenon and endotenon (Party et al., 1978). At first the extrinsic tissue repair 
predominates. In this manner the tissue defect is filled with granulation tissue of extrinsic 
origin. The fibroblasts, which migrate into the area of the injury, have phagocytic properties 
and at first are found in a radiating pattern along the length of the tendon. During this 
inflammatory phase the defect zone is filled with tissue that includes parts of the ruptured 
tendon and hematoma and the biomechanical stability is dependent on the fibrin fibers (Lou 
et al., 1996). 
Around the fifth day the fibroblasts, which have migrated into the wound area, start to 
synthesize collagen. Initially there is no uniform orientation of the newly formed collagen 
fibers. They contribute to a great degree to the biomechanical stability of the defect zone. 
Fibroblasts are the dominant cell type within the lesion and the collagen component 
increases continuously until the fifth week. 
In the fourth week increased proliferation of fibroblasts of intrinsic origin occurs. These 
fibroblasts are mostly derived from the endotenon and actively remodel collagen. As tissue 
maturation proceeds collagen fibers increasingly orient themselves along the functional 
stress axis of the tendon. This reparative phase takes place approximately two months after 
injury. 
 
Time 
(days) 
Phase Process 
0 Immediately post-
injury 
Clot formation around the wound 
0-1 
 
 
1-2  
Inflammatory First battery of growth factors and inflammatory 
molecules produced by cells within the blood clot 
 
Invasion by extrinsic cells, phagocytosis 
2-4 Proliferation Further invasion by extrinsic cells, followed by a 
second battery of growth factors that stimulate 
fibroblast proliferation  
4-7 
 
 
7-14 
Reparative Collagen deposition; granulation tissue formation; 
revascularisation 
 
Injury site becomes more organised; extracellular 
matrix is produced in large amounts 
14-21 
 
 
21+ 
Remodelling Decreases in cellular and vascular content; increases 
in collagen type I 
 
Collagen continues to become more organised and 
cross-linked with healthy matrix outside the injury 
area. Collagen ratios, water content and cellularity 
begin to approach normal levels 
Table 1. Summary of the healing process in tendons and ligaments. From Molloy et al., 2003. 
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Final biomechanical stability is achieved in response to resuming normal movement. During 
this period further organization of the collagen fibers along the stress axis of the tendon 
occurs. In addition, tensile strength is increased through cross-linking between the collagen 
fibrils. There is a shift from the synthesis of type III collagen to the mechanically more stable 
type I collagen (Möller et al., 1998; Pierce et al., 1995). There is no complete regeneration of 
the tendon lesion in spite of the intensive remodeling in the initial months after injury. The 
repaired tissue remains hypercellular and there is a shift in favor of thinner collagen fibrils, 
which compromises its biomechanical characteristics (Maffulli et al., 2002; Möller et al., 
1998). In the flexor tendon, an increased production of type III collagen is seen up to 14 
months after injury (Pierce et al., 1995). These results are mirrored in a reduced collagen 
fibrillar diameter, which is seen after tendon injury (Janqueira et al., 1978; Möller et al., 
1998). The concentration of collagen type III with this type of regenerate is inversely 
proportional with the mechanical resilience of the healed tendon (Laemmli, 1970). 
Collagen type analyses performed after Achilles tendon rupture indicate a decrease in 
collagen type I alongside a significant increase in the amount of collagen type III (Ducy & 
Karsenty, 2003). An elevation of the amount of collagen type III is thought to be the cause of 
reduced tensile strength in connective tissue due to the reduced cross-linking of this 
collagen type (Janqueira et al., 1978, Jozsa et al., 1984; Lou et al., 1997, Maffulli et al. 2002). 
This phenomenon is involved in the pathogenesis of degenerative tendinopathies such as 
with achillodynia and degenerative rotator cuff lesions (Lou et al., 1997). The development 
of hypertrophic, biomechanical inferior, replacement tissue is caused by recurrent 
microtrauma. 
2.4 Influence of growth factors 
Cellular growth factors and cytokines play key roles during embryonic tissue differentiation 
and during wound healing (Gabra et al, 1994; Goomer et al. 2000; Grotendorst et al., 1985; 
Hudson-Goodman et al., 1990; Mason & Allen 1941). Growth factors are known to stimulate 
cell differentiation, chemotaxis, angiogenesis, and extracellular cell matrix synthesis (Mason 
& Allen 1941; Nakamura et al., 1996; Nakamura et al., 1998). Furthermore, these factors 
regulate cellular synthesis and the secretion activity from matrix components and influence 
in this manner the course and results of would-healing (Gabra et al., 1994; Lou et al., 1997). 
The diversity of the cytokinetic characteristics lends credence to the concept that these 
growth factors are potentially capable of modulating the tendon healing processes, resulting 
in better healing (Mason & Allen 1941).  
The influence of growth factors on tendon healing has been investigated through 
comparative studies of the profiles of cytokines of injured and normal tendons. It has been 
shown that wounding and inflammation provoke release of growth factors (Nakamura et 
al., 1996; Nakamura et al., 1998; Party et al 1978).  
2.4.1 PDGF 
However, healing tendons have increased PDGF-concentrations (Enzura et al., 1996; 
Nakamura et al., 1996; Nakamura et al., 1998). Under the influence of PDGF, rates of 
fibroblasts proliferation, chemotaxis and collagen synthesis are somewhat elevated (O'Brien 
T, 1992). However, patellar tendon fibroblasts show higher proliferation after the addition of 
bFGF in vitro (Coombs et al., 1980) 
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As Molloy wrote at his review, PDGF describes a group of dimeric polypeptide isoforms 
made up from three types of structurally similar subunits. Its activity is mediated through 
its interaction with two related tyrosine kinase receptors, one of which binds all three PDGF 
chains, and the other binds only one (Ronnstrand et al). Work by Duffy et al. (1995) has 
shown that PDGF is elevated in the healing canine digital flexor tendon, suggesting a role in 
the healing process. It is thought to play a significant role in the early stages of healing, at 
which time it induces the synthesis of other growth factors, such as IGF-I (Lynch et al, 1989). 
In vitro studies by Yoshikawa and Abrahamsson (2001) on PDGF have further 
demonstrated that this growth factor also plays an important role during tissue remodelling. 
PDGF was observed to stimulate both collagen and non-collagen protein production, as well 
as DNA synthesis, in a dose-dependent manner. 
One theory that has been put forward as to how PDGF increases protein production 
involves its induction of TGFβ-1 expression (Pierce et al., 1989). However, in vivo studies by 
Hildebrand et al. (1998) in which the PDGF isomer PDGF-BB was applied to the healing 
MCL of the rabbit with and without TGFβ-1 showed no such complementary effect. In fact, 
addition of PDGF-BB and TGFβ-1 together resulted in poorer healing (as determined by 
ultimate load, energy absorbed to failure, and ultimate elongation values) than addition of 
PDGF-BB alone. Stimulation of DNA synthesis by PDGF has also been postulated to occur 
through a growth factor second messenger. In this case, increases in PDGF have been shown 
to result in up-regulation of IGF-I and IGF receptors, that once activated stimulate DNA 
synthesis (Lymch et al 1989). A significant amount of the PDGF produced for this end is 
thought to come from an exogenous source, probably from platelets (Tsuzaki et al., 2000). 
Interestingly, the level of stimulation has been shown to be specific to the site and type of 
tendon examined. In studies by Yoshikawa and Abrahamsson (2001) DNA synthesis was 
stimulated to higher levels in intermediate compared with intrasynovial tendons, and 
protein synthesis was higher in proxi- mal intrasynovial tendon segments than in 
extrasynovial peroneal tendon segments (Molloy et al, 2003). 
2.4.2 VEGF 
VEGF is required for the formation of the initial vascular plexus early in granulation tissue 
development and contributes to vascular bud formation and endotheliocyte migration 
during neo-vascularization, which occurs at the primary stage of tendon healing. However, 
his results suggest that VEGF deteriorated tendon properties via vessel formation and 
destruction of the collagen network while TGF-β enhanced the tendon mechanical 
properties.  
VEGF is not normally found in adult tendon, but is expressed in the healing tendon, 
alongside with increased expression of the VEGF receptors 1 and 2 in areas with great 
microvascular density (Petersen et al., 2003b)[18]. When added to a healing tendon, VEGF 
increases the vascularization from 1 to 8 weeks after rupture (Hou et al., 2009)[7]. Although 
the mechanical properties are better at 1 week, the difference is no longer significant after 
only 2 weeks (Zhang et al., 2003)[29]. Since prior to the formation of new vessels there is an 
increase of matrix metalloproteases and the vascular tissue has inferior mechanical 
properties compared to a tendon, this may explain the afore mentioned observation. Our 
findings suggest that VEGF is tightly controlled during at least 8 weeks in tendon healing 
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without big increases or decreases in concentration, but possibly with a slight decrease up to 
8 weeks. TGF-β may exert some control over the expression of VEGF by depressing it (Hou 
et al., 2009)[7], but other pathways such as endostatin are also possible (Pufe et al., 2003)[20]. 
2.4.3 TGF-β 
TGF-β1 is known to play an important role in the healing process of injured tendon by 
directing the fibroblast migration (Roberts et al.,1988), neovascularization and secretion of 
extracellular matrix proteins like procollagen type I and III (Kashiwagi et al., 2004). 
When TGF is added to the healing tendon, it has been shown to induce the expression of 
collagen I and III and also improve the mechanical properties of the tendon, seemingly 
accelerating the healing process (Hou et al., 2009; Kashiwagi et al., 2004). It may be that a 
single exposure to TGF-β in sufficient dosage is already enough to mobilize and differentiate 
additional mesenchymal stem cells (Kashiwagi et al., 2004). Normally TGF-β is expressed 
early in a healing tendon in the process of inflammation and reorganization at 4 and 7 days, 
whereafter the expression decreases at 2 and 4 weeks (Chan et al., 2003). Loading and 
mobilization of the tendon seem to decrease the expression of TGF-β (Eliasson et al., 2009), 
possibly reducing the initial inflammation in the healing tendon. At the end stage of tendon 
healing TGF-β may also promote the apoptosis of fibrocytes (Jorgensen et al., 2005; Lui et al., 
2007). In our one studies we observe a high concentration of TGF-β initially, which then 
decreased for 2 and 4 weeks and then increase massively at 8 weeks, possibly reflecting the 
initial inflammation and activation of cells, followed by an intermediary period and then the 
remodeling of the tendon with increased apoptosis of no longer necessary cells. The results 
are similar to those for the rat rotatory cuff (Würgler-Hauri et al., 2007), although we 
observe a steeper increase at 8 weeks. 
2.4.4 BMP-12 
Several BMPs are able to induce bone and cartilage formation in animals by influencing the 
differentiation of mesenchymal progenitor cells along the cartilage, or bone lineage (Ducy & 
Karsenty, 2000; Wozney 1998). However, BMP-12, a human homologue of growth and 
differentiation factor 7 (GDF-7), does not induce bone or cartilage, BMP-12 induces the 
formation of tendon and ligament tissue (Enzura et al., 1996; Lou et al., 2001; Wolfman et al., 
1997). Therefore, BMP-12 plays an important role in tendon healing. In order to optimize 
tendon healing it seems to be important to have a high level of expression of collagen type I. 
Corresponding to this fact there must also be a transition from the initial production of 
collagen type III to type I. 
A natural course of BMP-12 expression has been measured in loaded rat achilles tendons 
although without the plantaris tendon to act as an internal splint which would mechanically 
stabilize the healing tendon in the early stages (Eliason et al., 2008). The resulting expression 
patterns have suggested an initially high expression of BMP-12 at the beginning of tendon 
healing at 3 days, followed by a decrease at 8 days even below the normal expression and 
up to 21 days a further slight decrease. At the same time loading of the healing tendon 
showed a decrease of the expression of follistatin, an inhibitor of BMP-12 (Eliason et al., 
2008). Our data accordingly also shows an initially higher concentration of BMP-12 and 
subsequent decrease after 2 weeks. Because we have measured the concentration directly as 
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opposed to the cellular expression, the time points are somewhat shifted, and it may be that 
the higher concentration of BMP-12 acts in a negative feedback loop to prevent further BMP-
12 expression. The effects of BMP-12 when added in a tendon healing model include the 
increase of tendon callus and the improvement of mechanical properties such as overall 
strength and stiffness, both after 1 week (Forslund et al., 2003; Majewski et al., 2008). 
However BMP-12 added during the first week of healing leads to a more organized tendon 
tissue (Murray et al., 2007), higher volumes of collagen I and an earlier shift of fibroblasts to 
fibrocytes (Majewski et al., 2008). Our results thus suggest a tightly controlled BMP-12 
concentration, which possibly helps to coordinate the newly produced cells during 
proliferation in the early healing period. This is also seen with the rat rotatory cuff (Würgler-
Hauri et al., 2007), yet we do not see an increase in concentrations after 8 weeks, again 
possibly reflecting the difference in both tendons. 
2.4.5 bFGF 
Use of bFGF in a healing tendon has been shown to increase cellularity early in the healing 
process (Chan et al., 2008). While reducing expression of collagen I and III in the first week 
(Thomopoulos et al., 2010), it increased both after two weeks (Sahoo et al, 2010), again 
suggesting a prolonged phase of proliferation, associated with a higher repair potential in a 
normally bradytrophic tissue. Extracellular matrix changes associated with bFGF are an 
increase of lubricants and matrix metalloproteases during the first week, supposedly 
creating the space needed for the additional tenoblasts and tenocytes (Thomopoulos et al., 
2010). The initial increase in bFGF we have observed in our study may thus reflect an early 
phase of the healing process, which provides the tenocytes and fibroblasts needed for the 
repair of the extracellular matrix by stimulating their proliferation. This is in accordance 
with the study done in the rat rotatory cuff (Würgler-Hauri et al., 2007), but we have not 
observed the increase of bFGF after 8 weeks which possibly reflects one of the many 
differences of the achilles tendon and rotatory cuff. 
2.4.6 IGF 
During the initial repair process and the inflammatory phase, upregulation of growth 
factors and cytokines such as insulin-like growth factor-1 (IGF-1) stimulate the migration 
and proliferation of fibroblasts and inflammatory cells to the wound site (James et al., 2008; 
Kurtz et al., 1999; Tsuzaki et al., 2010). Several studies have shown that IGF-I is locally 
increased during and after inflammation following soft tissue injury, both at the mRNA and 
protein levels, and is associated with a corresponding up-regulation of its receptors (Bos et 
al., 2001; Edwall et al., 1989; Fortier et al.; 2001; Molloy et al., 2003; Rubini et al., 1994 Sciore 
et al., 1998; Tsuzaki et al., 2000; Vogt et al., 1998). James mentioned, that Insulin-like growth 
factor-1 may be stored as an inactive precursor protein in normal tendon and, upon injury, 
enzymes release the growth factor to exert its biological activity. During the later phases 
such as remodeling, IGF-1 stimulates synthesis of collagen and other extracellular matrix 
components; studies in vitro have shown that the effects of IGF-1 on matrix metabolism are 
dose dependent (James et al., 2008). As Molloy stated, its primary roles seem to be to 
stimulate the proliferation and migration of fibroblasts and other cells at the site of injury, 
and to subsequently increase the production of collagens and other extracellular matrix 
structures in these cells during the remodelling stages. Because IGF-I is such a versatile and 
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widespread signal molecule, it has numerous and varied activities during tendon healing, 
particularly when working in concert with other growth factors. As with many other 
cytokines, synergism with other molecules is important for its stimulatory acivity. It is 
thought that IGF-I works to promote cell proliferation when in the presence of other growth 
factors, such as the PDGF isomer PDGF-BB (Molloy et al., 2003). 
 
Repair phase Activity Growth Factor 
Inflammatory Stimulates recruitment of fibroblasts and 
inflammatory cells to the injury site 
Regulation of cell migration 
Expression and attraction of other growth factors (e.g. 
IGF-1) 
Angiogenesis 
IGF-1 
TGF-β 
PDGF 
VEGF, bFGF 
Proliferative Cell proliferation (DNA synthesis) 
Stimulates synthesis of collagen and ECM 
components 
Stimulates cell-matrix interactions 
Collagen Type III synthesis 
IGF-1, PDGF, TGF-β, 
bFGF, GDF-5,-6,-7 
IGF-1, PDGF, bFGF 
TGF-β, bFGF 
TGF-β, GDF-5,-6,-7 
Remodelling ECM remodelling 
Termination of cell proliferation 
Collagen type I synthesis 
IGF-1 
TGF-β 
TGF-β, GDF-5,-6,-7 
Table 2. Tendon repair phases with biological characteristics and ensuing molecular events 
that are regulated by several cytokines or growth factors (from James et al., 2008) 
2.4.7 Platelet-rich plasma 
Lately platelet-rich plasma is being progressively used to treat musculoskeletal conditions. 
Within their alpha granules and dense granules platelets have a rich store of factors and 
cytokines. Among others the alpha granules contain PDGF, TGF-β, IGF-1, VEGF, and EGF, 
whereas the dense granules contain neuromodulators and inflammatory modulators such as 
histamine and serotonin. By exposure to collagen, thrombin, or calcium platelets release 
these growth factors and cytokines (Fufa et al., 2008; Rodeo et al., 2010). For the treatment of 
chronic Achilles tendinopathy a randomized, double blind, placebo-controlled trial 
demonstrated no significant differences between patients managed with either platelet-rich 
plasma or saline solution injections (DeVos et al., 2010; Rodeo et al., 2010). In a prospective, 
randomized trial platelet-rich-fibrin-augmented rotator cuff repairs showed increased 
vascularization compared to the control group six but not twelve weeks postoperatively 
(Rodeo et al., 2010). Repaired superficial digital flexor tendons in front limbs of horses had a 
higher failure strength and greater elastic modulus 24 weeks postoperatively after being 
treated with platelet rich plasma compared to the control group with only saline injection. 
Histologically the platelet-rich plasma group demonstrated better collagen organization and 
increased metabolic activity (Bosch et al., 2010). 
2.4.8 Autologeous conditioned serum 
During our own studies on 80 male Sprague Dawley rats we found a marked increase of 
collagen type I and a decrease of collagen type III in animals treated with ACS (Majewski 
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et al. 2009). An increased content of type III collagen in the fibers would tend to reduce 
their tensile strength (Jozsa et al, 1984; Jozsa et al, 1990; Maffulli et al, 2000; Matthew & 
Moore, 1991). ACS-treated animals showed markedly more mature, thick reddish/orange 
collagen fibers at weeks 2 and 8 postoperatively as compared with controls and 
quantitative evaluation of collagen type III showed a three fold reduced level of this 
collagen at weeks 1, 2 and 8. This finding is in agreement with the reports of Aspenberg 
and Virchenko who documented a beneficial effect of platelet concentrate administration 
on the histological appearance of the healing tendon, with a concomitant increased tendon 
callus strength and stiffness by about 30% after week 1, an improvement which persisted 
for as long as 3 weeks after the injection (Aspenberg & Virchenko, 2004; Wright-Carpenter 
et al2004). Despite the improved collagen synthesis, which is apparent from the 
significantly greater tendon thickness at weeks 1, 4 and 8, stiffness was significantly 
(P=0.038) increased at week 4.  
In summary, it is clearly evident that ACS injections accelerate the rate of organization of 
repair tendon tissue. ACS injections apparently do not critically limit inflammatory signals 
of the early healing phase but supplement critical growth factors that are present in serum 
in limiting concentrations. The biologically active components in ACS are responsible for the 
observed accelerated Achilles tendon healing (Majewski et al. 2009).  
2.5 Natural course of healing 
The normal course of tendon healing with an emphasis on growth factor expression has 
been studied for various models of  tendon pathology, including rotatory cuff tears and 
Achilles tendon ruptures in a rat model as well as in tenocyte cultures. However only a few 
studies have focused on the expression of several growth factors over time. Indications as to 
which growth factors are at work at what time during tendon healing can be emerge from 
studies on the temporal growth factors expression during unaided healing as well as from 
studies on the effects of local growth factor administration. As to the unaided healing, 
Würgler-Hauri and coworkers documented the temporal expression of growth factors in 
tendon-to-bone healing in a rat supraspinatus model using immunohistochemical staining . 
Their results show that all growth factors measured increase at weeks 1 and 2, as well as at 
week 8 (Würgler-Hauri et al., 2007).  
As tendons vary greatly in function and structure, we studied the expression during healing 
over time of bFGF, BMP-12, VEGF and TGF-β in a rat Achilles tendon healing model. After 
surgically introduced, immunohistological analysis was performed for 1, 2, 4 and 8 weeks of 
healing. Results showed a high initial concentration of bFGF and BMP-12, which sank 
rapidly after 2 weeks, while VEGF remained elevated just slowly decreasing over time and 
TGF-β even increased after 8 weeks. The observed difference compared to the rotatory cuff 
model is maybe due to tendon-to-tendon versus tendon-to-bone healing. 
3. Tissue engineering 
3.1 Cytokines modulation 
Growth factors and cytokines modulate the differentiation of tendons during embryogenesis 
and play also an important role  during the healing process of tendons (Grotendorst, 1988; 
Hudson-Goodman et al, 1990). In healthy canine flexor tendons an increased expression of 
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bFGF was measured whereas the amount of PDGF was increased in healing tendons (Duffy 
et al, 1995). Under the influence of PDGF an increased chemotaxis of fibroblasts, 
proliferation rate and collagen synthesis was observed (Grotendorst, 1988; Pierce et al, 1995). 
bFGF caused an increased fibroblast proliferation in in vitro Achilles tendons and an 
angiogenic effect of bFGF has been shown (Chan, et al; 1997; Gabra et al, 1994). During 
tendon embryogenesis bone morphogenetic proteins (BMP), especially BMP 12 and 13 cause 
the expression of elastin and collagen I. In animal studies BMP 12 induced healing of the 
patellar tendon (Möller et al, 2000). In in vitro studies an increased mRNA expression of 
type I collagen by the transforming growth factor * family (TGF*) has been shown. 
3.2 Scaffolds 
Lately biocompatible and biodegradable scaffolds are also used in tissue engineering of 
tendon healing. They are thought to mimic native extracellular matrix in the beginning of 
tendon healing. Moreover scaffolds are supposed to hold cells that are involved in the 
tendon healing either by being implanted or chemo-attracted to the scaffold (Gott et al, 
2011). Combination of scaffolds and tenocytes led to superior histologic and 
biomechanical repairs in flexor tendons compared to scaffolds without tenocytes. 
However, the use of scaffolds might impair tendon gliding within narrow synovial 
sheaths (Adams et al., 2006; Cao et al., 2002; Gott et al, 2011). The positive affect of 
scaffolds in Achilles tendon and rotator cuff repair is rather achieved by combination with 
other tissue engineering modalities e.g. growth factors or bio-adhesiv coat than by the 
structural support alone, which showed to be not sufficient enough. Pericardium or 
dermal tissue that was augmented with a bioadhesive coating showed improved 
biomechanical properties compered to control in an Achilles tendon model (Brodie et al., 
2011; Derwin et al., 2006; Gott et al, 2011). In a rabbit model a polyglycolic-acid scaffold 
combined with fibrin was seeded with Achilles tenocytes and then implanted in a defined 
Achilles tendon defect. Compared to the control groups (scaffold alone and without 
scaffold) macroscopic and microscopic appearance was superior. Unfortunately no 
biomechanical testing was performed in this study (Stoll et al. 2011). In massive rotator 
cuff tear a functioning scaffold model is desirable. Nevertheless the goal remains to create 
a tension-free, anatomical repair that restores the footprint as scaffolds have not yet 
shown to have the adequate biomechanical power (Nho et al, 2010). In this field more 
research is need to be done. Rather the biologic part than the mechanic part seems to be 
promising in the use of scaffolds. 
3.3 Gene intervention 
Several investigators have studied gene transfer to tendons. Three model systems have been 
used; the patellar tendon of the  knee (Gerich et al., 1996; Nakamura et al., 1996), the digital 
flexor tendon (Goomer et al. 2000, Lou et al., 1996, Lou et al., 1997, Lou et al., 2001), and the 
Achilles tendon (Dai et al., 2003). In these model systems, repair strength and gap formation 
of the tendon scar is important while with digital flexor tendons a second, equally important 
issue is adhesion formation between the healing tendon and the surrounding tendon pulley 
sheaths.  
The investigators considered the feasibility of gene transfer in digital flexor tendons of 
chickens and dogs, and patellar or Achilles tendons of rats [5,13,25,35]. Nakamura, used the 
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HVJ-liposome construct to deliver ß-galactosidase to a rat patellar tendon [35]. 
Approximately 7% of the cells were ß-galactosidase positive 7 days after injection and this 
decreased to 0.2% of cells 56 days after injection. [35]. Digital flexor tendons in dogs and 
chickens were modified using cationic liposomes and expression vector containing ß-
galactosidase to enhance transfection [13,25]. 6 days later the transfection efficiencies were 
reported as 100% [13]. The authors reported no evidence of immune response.  
The second digital flexor tendon model was that of chicken flexor tendons [25]. ß-
galactosidase expression was detected in the tendon and tendon sheath at 3, 30 and 75 days 
after injection. An estimated 2-5% of cells were ß-galactosidase positive and most of these 
cells were on the surfaces of the tendon and tendon sheath [25]. The fourth study used a 
transected rat Achilles tendon model without suturing to evaluate ß-galactosidase 
expression [5]. At 4 days after transection, recombinant adenovirus carrying LacZ was 
placed in the transection site. The authors detected ß-galactosidase expression up to 17 days 
after injection and 21 days after transection. Transduction rates increased with higher doses 
of injected virus [5]. The previous four studies with tendons used direct injection of the 
vectors in or around the tendons.  
Oezkan investigated the feasibility of intra-arterial injection of HVJ-liposomes for 
transfecting cells of the patellar tendon and found that between 8 and 12% of the cells 
positive [38].  
Three studies have tried to manipulate the healing environment of tendons [27,26,36]. Two 
studies evaluated digital flexor tendons, studying adhesion formation and the tendon scar 
strength [26,27]. Lou, used gene intervention to manipulate the healing environment of 
chicken digital flexor tendons to investigate tendon adhesions [26].  
Lou did a study in chicken digital flexor tendon. They used an adenoviral construct with 
BMP-12 to transduce primary chicken tendon cells in vitro. Collagen Type I synthesis was 
increased 30% by cells transduced with the adenoviral-BMP-12 construct when compared to 
control cells or cells transduced with an adenovirus-ß-galactosidase construct. While there 
were no significant differences in the ultimate failure force or the stiffness at 2 weeks, by 4 
weeks these values for adenoviral-BMP-12 group were approximately significant greater 
than the values of adenoviral- ß-galactosidase group [27]. 
4. How to best improve tendon healing with growth factors 
Tendon ruptures and tears are slow healing common injuries that are often treated 
surgically with unsatisfactory results for some patients. As the biology of the healing 
process and how it is influenced by growth factors become clear, one can consider 
introducing biological therapy into clinical use. As data on the effect of specific recombinant 
growth factors were mainly obtained from studies in different animal models of tendon 
healing, these are difficult to compare.  
In our own studies we have compared the benefits of three different approaches of tendon 
healing influenced by growth factors: TGF-β as an example for multifunctional growth 
factors inducing a wide range of cellular responses, BMP-12 as example for the specific 
induction of tendon and ligament tissue, and a growth factor cytokine mix derived from 
serum and activated platelets as an example for biological therapy. 
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We hypothesized that the interplay of numerous growth factors and cytokines contributes to 
optimal tendon healing. We reasoned that the growth factors normally present in serum and 
released by activated platelets could approximate the growth factor/cytokine mix seen by 
the injured tendon better then when single growth factors are applied.  
The transected rat Achilles tendon was used for the evaluation of the effect of all growth 
factors. Doing a pre-study, staining intensity for BMP-12, bFGF, TGF β, and VEGF showed 
that all these factors are highly expressed at the early stage of healing.  
 
Fig. 1. Relative Growth factor Expression in correlation to the time after injury. A relative 
high expression was measured within the first week. TGF-β tends to rise again after 4 
weeks, whereas the others remain at a stable level after two weeks.  
Therefore, BMP-12 cDNA, and separately TGF-β cDNA were introduced at the time of 
surgery and activated serum  (ACS) was injected at the time of tendon surgery as well as 24 
and 48 postoperatively. Animals were sacrificed 1, 2, 4, and 8 weeks later and Achilles 
tendon tendon-bone units were collected. Biomechanical testing, histochemical and 
immunochemical analyses of regenerate sections were performed using standard 
techniques.  
4.1 Biomechanical testing 
TGF-β: Biomechanical testing of the healing rat Achilles tendon showed an increased 
maximum load. The maximum failure load was significantly increased one week after 
surgery, compared to the control (p=0.0012), and was also somewhat higher after 4 and 8 
weeks. Tendon stiffness was significantly higher after one week. 
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BMP-12: Tendons exposed to BMP-12 showed significantly greater strength (P=0.0379) than 
controls at 1 week. Tendon stiffness was significantly higher at 1, 2 and 4 weeks Control 
tendons, in contrast, only achieved normal stiffness values after 8 weeks. 
AS: AS-tendons reached stiffness values 4 weeks earlier than the controls. There were no 
differences in maximum load to failure between groups up to week 8. 
4.2 Histology 
TGF-β: Histological examination showed a much more organized and homogeneous pattern 
of collagen fibers over all time points compared to controls. The fibers grew to bigger 
bundles much earlier with a higher degree of collagen crimp.  
BMP-12: The Histological examination was quite similar compared to TGF-β group. 
However, after 8 weeks, there was one tendon with an enchondral ossification at the 
experimental group. 
AS: Collagen fibers were apparent as early as week 1 postoperatively. These collagen fibers 
were visibly thicker and more bundled than in all other tendon at this stage. The trend 
toward better organized collagen continued in week 2 and 4. At 8 weeks postoperatively, 
the tendons had a smooth appearance resembling very much normal tendons with small 
fibrocartilaginous areas in the center of the stress areas. 
 
Control TGF-β 
BMP-12 AS 
Fig. 2. Effect of different Growth Factor on the histologic appearance of the repair site. 
Sections were made from tendons recovered 1 week after surgery and stained with 
hematoxylin and eosine. Magnification: x200. 
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4.3 Collagen 
Control tendons contain mainly collagen I, and approximately 3% collagen III. In 
regenerates formed under the influence of TGF-β this collagen ratio is reached after 2 weeks. 
With BMP-12 stimulation a collagen III content of 3% is reached by week 4, and with AS by 
week 8. 
 
 Biomechanics Ratio collagen type 
I/III 
Histology 
TGF-β + +++ + 
BMP-12 ++ ++ +/(-) 
Biological therapy 
(ACS) 
- + +++ 
Table 3. Effects of growth-factors on transected rat Achilles tendon healing 
4.4 Conclusions 
Our data indicate that the mix of growth factors and cytokines in activated serum yields 
superior tendon healing than single growth factors as judged by histological appearance of 
the regenerate. However, growth factors BMP-12 and TGF-β yielded better biomechanical 
results and more favorable collagen expression ratios, respectively. As tendon ruptures and 
tears are slow healing injuries, the quality of life and economic productivity of patients is 
often diminished for weeks. It would benefit patients greatly if the healing process could be 
accelerated and improved by biological intervention as appears possible from our data. At 
present it is not clear which of the approaches of growth factor delivery is most promising 
as each of them yields better outcomes in a respect or another (collagen ratio, histological 
appearance, biomechanical properties). Further studies are needed to determine whether it 
is possible to obtain normal tendon tissue by growth factor application.  
5. Abbreviations 
ACS  autologous conditioned serum  
bFGF   basic fibroblast growth factor  
BMP   bone morphogenetic protein  
CDMP  cartilage-derived morphogenetic protein 
EGF  epidermal growth factor 
GDF   growth and differentiation factor 
IGF  insulin-like growth factor 
PDGF  platelet-derived growth factor 
PRP  platelet-rich plasma 
TGF-β   transforming growth factor beta   
VEGF   vascular endothelial growth factor 
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